Roughly two years after securing a former Novartis facility in Illinois to support its CAR-T cancer treatments Breyanzi and Abecma, Bristol Myers Squibb is rethinking its operations at the site. BMS ...
What are your biggest concerns around rising costs for cell therapies? What’s important to think about concerning the costs of cell therapies is that bringing costs down will increase our ability to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results